Brief: Maxcyte Announces Operational Restructuring To Reduce Costs
Sept 22 (Reuters) - MaxCyte Inc MXCT.O: MAXCYTE ANNOUNCES OPERATIONAL RESTRUCTURING TO REDUCE COSTS AND ACCELERATE PATH TO PROFITABILITY MAXCYTE INC - TO REDUCE 34% OF GLOBAL WORKFORCE MAXCYTE INC - EXPECTS $13.6 MILLION IN ANNUALIZED SAVINGS FROM RESTRUCTURING MAXCYTE INC - EXPECTS 2025 CORE REVENUE FLAT TO DOWN 10% Source text: ID:nGNXCq9Kk Further company coverage: MXCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsMaxCyte Q1 revenue falls
Brief: Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer
Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments
Brief: MaxCyte Announces Planned CFO Transition In 2026